These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24340558)

  • 21. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host and pathogen factors for Clostridium difficile infection and colonization.
    Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
    N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term effect of infection control practices and associated factors during a major Clostridium difficile outbreak in Costa Rica.
    Wong-McClure RA; Ramírez-Salas E; Mora-Brenes N; Aguero-Sandí L; Morera-Sigler M; Badilla-Vargas X; Hernández-de Merzerville M; O'Shea M; Bryce E
    J Infect Dev Ctries; 2013 Dec; 7(12):914-21. PubMed ID: 24334937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).
    Ticinesi A; Nouvenne A; Folesani G; Prati B; Morelli I; Guida L; Turroni F; Ventura M; Lauretani F; Maggio M; Meschi T
    BMJ Open; 2015 Oct; 5(10):e009316. PubMed ID: 26503394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital.
    Price MF; Dao-Tran T; Garey KW; Graham G; Gentry LO; Dhungana L; Dupont HL
    J Hosp Infect; 2007 Jan; 65(1):42-6. PubMed ID: 17145108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients.
    Shehabi AA; Abu-Ragheb HA; Allaham NA
    East Mediterr Health J; 2001; 7(4-5):750-5. PubMed ID: 15332775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.
    Lee YC; Wang JT; Chen AC; Sheng WH; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2012 Aug; 45(4):287-95. PubMed ID: 22209696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for the development of Clostridium difficile infection in hospitalized children.
    Samady W; Pong A; Fisher E
    Curr Opin Pediatr; 2014 Oct; 26(5):568-72. PubMed ID: 25032717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiological and clinical analysis of Clostridium difficile infections in patients hospitalized due to the infection at the Department of Infectious Diseases in Bytom.
    Stolarz W; Sobala-Szczygieł B; Piotrowski D; Kępa L; Oczko-Grzesik B; Boroń-Kaczmarska A
    Przegl Epidemiol; 2015; 69(4):711-6, 857-60. PubMed ID: 27139349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of nosocomial acquired Clostridium difficile infection in an Italian research and teaching hospital.
    Bertizzolo L; Domeniconi G; Fabio G; Jacchetti G; Serafino S; Formica S; Nobile M; Castaldi S
    Ann Ig; 2013; 25(2):119-24. PubMed ID: 23471449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.
    Dial S; Kezouh A; Dascal A; Barkun A; Suissa S
    CMAJ; 2008 Oct; 179(8):767-72. PubMed ID: 18838451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
    Asha NJ; Tompkins D; Wilcox MH
    J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use.
    Shek FW; Stacey BS; Rendell J; Hellier MD; Hanson PJ
    J Hosp Infect; 2000 Jul; 45(3):235-7. PubMed ID: 10896804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.